Medscape

Jose R. Arribas, MD
Disclosure: Jose R. Arribas, MD, has disclosed that he has received consulting fees from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Tibotec, and Roche.

Anton L. Pozniak, MD
Disclosure: Anton L. Pozniak, MD, has disclosed that he has received consulting fees, educational and travel grants from Gilead Sciences, GlaxoSmithKline, Roche, Tibotec, and Bristol-Myers Squibb.

Joel E. Gallant, MD, MPH
Disclosure: Joel E. Gallant, MD, MPH, has disclosed that he has received consulting fees, grant/research support, or honoraria from Abbott Laboratories, Boehringer Ingelheim, Roche Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Merck, Tibotec, Panacos, Monogram Biosciences, Schering-Plough, Pfizer, and Bristol-Myers Squibb.

Edwin DeJesus, MD
Disclosure: Edwin DeJesus, MD, has disclosed that he has received consulting fees or research support from Gilead Sciences, GlaxoSmithKline, Roche Pharmaceuticals, and Bristol-Myers Squibb.

Brian Gazzard, MD
Disclosure: Brian Gazzard, MD, has disclosed that he has received consulting fees from Gilead Sciences, GlaxoSmithKline, and Bristol-Myers Squibb.

Rafael E. Campo, MD
Disclosure: Rafael E. Campo, MD, has disclosed that he is a clinical investigator, clinical grant recipient, and speaker for Gilead Sciences, GlaxoSmithKline, Abbott Laboratories, Merck, Pfizer, and Bristol-Myers Squibb.

Shan-Shan Chen, MPH
Disclosure: Shan-Shan Chen, MPH, has disclosed no relevant financial relationships.

Damian McColl, PhD
Disclosure: Damian McColl, PhD, has disclosed no relevant financial relationships.

Charles B. Holmes, MD, MPH
Disclosure: Charles B. Holmes, MD, MPH, has disclosed no relevant financial relationships.

Jeffrey Enejosa, MD
Disclosure: Jeffrey Enejosa, MD, has disclosed no relevant financial relationships.

John J. Toole, MD, PhD
Disclosure: John J. Toole, MD, PhD, has disclosed no relevant financial relationships.

Andrew K. Cheng, MD, PhD
Disclosure: Andrew K. Cheng, MD, PhD, has disclosed no relevant financial relationships.

Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.

Paul A. Volberding, MD
Disclosure: Paul A. Volberding, MD, has disclosed that he has served as an advisor or consultant to Bristol-Myers Squibb, Gilead, Schering, Merck, GlaxoSmithKline, TaiMed, and Pfizer. Dr. Volberding has also disclosed that he has received grants from GlaxoSmithKline.